Clinical Trials Browser

Phase EARLY_PHASE1 × Leukemia, B-Cell × 90 days × Clear all

NCT06662227 2026-05-07

Universal CAR-T Cells (REVO-UWD-19) for Refractory and Relapsed B-Cell Tumors

Phase EARLY_PHASE1 Suspended

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Lymphoma, B-Cell